slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
790.000 KRW | -0,13% | +1,80% | +3,95% |
08:05 | Samsung Bioepis krijgt goedkeuring om auto-immuunbehandeling in Europa op de markt te brengen | MT |
07:19 | Samsung Biologics boekt meer winst en omzet in Q1 | MT |
Vakgebied
Aantal werknemers: 4 284
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Contract Development and Manufacturing Organization
72,4
%
| 2 337 523 | 77,9 % | 2 674 291 | 72,4 % | +14,41% |
Biopharmaceutical Development and Commercialization
27,6
%
| 663 772 | 22,1 % | 1 020 298 | 27,6 % | +53,71% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Europe
63,7
%
| 1 785 875 | 59,5 % | 2 353 845 | 63,7 % | +31,80% |
Americas
26,3
%
| 853 984 | 28,5 % | 971 055 | 26,3 % | +13,71% |
Other
6,9
%
| 206 690 | 6,9 % | 255 120 | 6,9 % | +23,43% |
South Korea
3,1
%
| 154 746 | 5,2 % | 114 569 | 3,1 % | -25,96% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Chongbo Rim
CEO | Chief Executive Officer | 62 | 01-01-18 |
Doyoung Heo
DFI | Director of Finance/CFO | - | - |
Tae-Han Kim
CHM | Chairman | 66 | 21-04-11 |
Yong-Ho An
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Hyung-Woo Moon
CMP | Compliance Officer | 54 | 01-01-17 |
Dong-Joong Kim
BRD | Director/Board Member | 59 | - |
James Choi
IRO | Public Communications Contact | 57 | 01-01-14 |
Sojeong Lee
LAW | General Counsel | - | 23-08-23 |
Connie Kim
PRN | Corporate Officer/Principal | - | 01-01-21 |
Park Yong
HRO | Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chang-Woo Lee
BRD | Director/Board Member | 70 | - |
Tae-Han Kim
CHM | Chairman | 66 | 21-04-11 |
Seok-Woo Jung
BRD | Director/Board Member | 62 | - |
Jae-Wan Park
BRD | Director/Board Member | 69 | - |
Dong-Joong Kim
BRD | Director/Board Member | 59 | - |
Soon-Jo Kwon
BRD | Director/Board Member | 59 | - |
Geun-Nyeong Heo
BRD | Director/Board Member | 68 | 22-03-19 |
John Chongbo Rim
CEO | Chief Executive Officer | 62 | 01-01-18 |
Eunice Kim
BRD | Director/Board Member | 65 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 71 174 000 | 17 974 713 ( 25,25 %) | 0 | 25,25 % |
Bedrijfsgegevens
SAMSUNG BIOLOGICS Co., Ltd.
300 Songdo Bio Way Yeonsu-gu
21987, Inchon
+
http://www.samsungbiologics.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,95% | 40,86 mld. | |
-2,86% | 87,31 mld. | |
-21,94% | 29,36 mld. | |
+54,25% | 24,49 mld. | |
-5,41% | 17,31 mld. | |
-44,23% | 11,26 mld. | |
-17,60% | 11,62 mld. | |
-13,96% | 11,31 mld. | |
+7,87% | 8,31 mld. | |
+2,09% | 7,63 mld. |
- Beurs
- Aandelen
- Koers A207940
- Onderneming Samsung Biologics Co.,Ltd.